Pulse Biosciences PLSE 深 滬
等待開盤 09-23 09:30:00 美东时间
52.69
-0.620
-1.16%
華盛通- 最 高53.7867
- 今 開53.23
- 成交量 37.22万股
- 最 低 52.485
- 昨 收 53.31
- 總市值 37.58亿
- 52周最高 58.90
- 市盈率 靜 --
- 換手率 0.52%
- 52周最低 12.56
- 委 比 32.12%
- 總股本 7132.26万
- 歷史最高 58.90
- 量 比 0.56
- 振 幅 2.44%
- 歷史最低 1.18
- 每 手 1
- 風險率 11.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulse Biosciences Launches New ATM Equity Program
Pulse Biosciences ( ($PLSE) ) has issued an update. On September 15, 2026, Puls...
09-16 04:57
Pulse Biosciences Completes Enrollment in PRECISE-BTN Study
Pulse Biosciences ( ($PLSE) ) has shared an update. On September 15, 2026, Puls...
09-15 21:18
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
Freedom Capital Markets Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $73
Freedom Capital Markets analyst Keith Hinton initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $73.
09-09 20:27
Top 3 Health Care Stocks That May Keep You Up At Night In Q3
As of Aug. 27, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices ...
08-27 20:46
Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58
Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.
08-17 18:36
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Pulse Biosciences shares are trading lower after the company reported worse-than-expected Q2 sales results.
Pulse Biosciences shares are trading lower after the company reported worse-than-expected Q2 sales results.
08-07 04:36
Biotech stocks lead healthcare's overbought list as earnings picks up
Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether recent rallies across biotech, medical technology and healthcare services can ...
07-23 19:18
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Friday. Shares of Apogee Enterprises Inc (NASDAQ:APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Adjusted diluted earnings came in at 57 cents per share, topping the a...
06-26 22:18
